IVERIC bio (ISEE) Tops Q3 EPS by 6c; Reports Cash and Cash Equivalents of $242.0M

IVERIC bio (NASDAQ: ISEE) reported Q3 EPS of ($0.23), $0.06 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on IVERIC bio (ISEE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c